Get a deeper look into your health.
Schedule online, results in a week
Clear guidance, follow-up care available
HSA/FSA Eligible
Biological Age Tests Compared: Which Method Actually Measures How Fast You're Aging?
Compare the 5 main biological age testing methods — epigenetic clocks, telomere length, blood biomarker panels, glycan analysis, and composite algorithms — by accuracy, cost, actionability, and what each actually measures. Includes optimal ranges and how to track your rate of aging over time.
Written by
Mito Health
Quick Summary
Compare the 5 main biological age testing methods — epigenetic clocks, telomere length, blood biomarker panels, glycan analysis, and composite algorithms — by accuracy, cost, actionability, and what each actually measures. Includes how to interpret results, which markers respond to intervention, and how to track your rate of aging over time.
You're 38 years old. A DNA methylation test says your biological age is 44. A blood biomarker algorithm says it's 33. Your telomere test came back "average for your age." You now have three numbers, three different methodologies, and no clear idea whether you're aging faster or slower than you should be.
This is the core problem with biological age testing in 2026 — there are at least five fundamentally different approaches, each measuring different aspects of the aging process, and they frequently disagree with each other. A person can have "young" epigenetic age and "old" telomeres simultaneously, because these tests aren't measuring the same thing. They're measuring different biological systems that age at different rates in different people.
The other issue — most biological age tests produce a single number that feels precise but obscures enormous uncertainty. An epigenetic clock that reports your age as 41.3 has a standard error of ±3–5 years. A telomere test that says you're "younger than average" tells you almost nothing about disease risk or how your body will respond to a specific intervention. The marketing around these tests is far more confident than the science supports.
This guide compares the five main biological age testing methods — what each actually measures, how accurate it is, how actionable the result is, and which approach gives you the most useful signal for tracking whether your longevity interventions are working.
Quick Decision Tree — Choose Your Biological Age Test in 30 Seconds
Want the most scientifically validated single measure of aging? Third-generation epigenetic clock (GrimAge2, DunedinPACE)
Want actionable markers you can improve in 3–6 months? Blood biomarker panel with composite scoring
Want to track rate of aging rather than a static age estimate? DunedinPACE (pace-of-aging clock)
On a budget and want a practical starting point? Comprehensive blood panel with longevity-relevant markers
Want the broadest aging picture? Combine blood biomarkers with an epigenetic clock annually
What Is Biological Age?
Biological age is a measure of how much physiological deterioration has occurred in your body relative to the average person of your chronological age. Two 45-year-olds can have dramatically different rates of organ function decline, disease risk, and cellular damage — biological age attempts to quantify that difference.
The concept is clinically meaningful. Research consistently shows that biological age predicts mortality, cardiovascular events, cancer incidence, and cognitive decline more accurately than chronological age alone [1]. The practical question isn't whether biological age matters — it's which measurement approach captures the most useful information.
There's an important distinction most testing companies gloss over: biological age (a static estimate of your cumulative aging) versus pace of aging (how fast you're currently aging). A 40-year-old with a biological age of 35 might still be aging faster than average right now. The static number tells you where you are. The pace tells you where you're heading. Both matter, but they require different measurement approaches.
The 5 Methods — At-a-Glance Comparison
Method | What It Measures | Accuracy (Test-Retest) | Actionability | Cost Range | Time to See Change |
|---|---|---|---|---|---|
Epigenetic Clocks (DNA Methylation) | CpG site methylation patterns across the genome | High (±2–4 years) | Moderate — slow to change | $200–$500 | 6–12 months |
Telomere Length | Terminal chromosome cap length | Low-Moderate (high variability) | Low — poor intervention sensitivity | $100–$300 | 12–24+ months |
Blood Biomarker Panels | Organ function, inflammation, metabolic health markers | Moderate-High (marker-dependent) | High — responds to lifestyle in weeks | $100–$500 | 4–12 weeks |
Glycan Analysis (GlycanAge) | IgG glycosylation patterns | Moderate (±3–5 years) | Moderate — responds to lifestyle in months | $300–$500 | 3–6 months |
Composite Algorithms | Multi-omic or multi-biomarker weighted scores | Varies by algorithm | High — combines multiple signals | $300–$1,000+ | Depends on inputs |
Epigenetic Clocks — DNA Methylation Testing
Epigenetic clocks are the most scientifically validated approach to biological age estimation. They work by analyzing DNA methylation patterns at specific CpG sites — chemical modifications that change predictably with age and are influenced by environmental exposures, lifestyle, and disease states [2].
Not all epigenetic clocks are equal. The field has gone through three generations, and the differences matter enormously for interpretation.
First-Generation Clocks (Horvath, Hannum)
These clocks were trained to predict chronological age from methylation data. They do this well — Horvath's multi-tissue clock achieves a correlation of r = 0.96 with chronological age across thousands of samples. The problem is that a clock trained to predict chronological age doesn't necessarily capture biological aging. Someone aging rapidly and someone aging slowly can produce similar readings if their methylation patterns happen to track chronological time rather than physiological decline.
Clinical utility: limited. These clocks detect large deviations from expected aging but lack sensitivity to lifestyle interventions.
Second-Generation Clocks (PhenoAge, GrimAge)
These clocks were trained to predict mortality and disease outcomes rather than chronological age. GrimAge, developed by Ake Lu and Steve Horvath, incorporates DNA methylation surrogates for plasma proteins associated with mortality — including PAI-1, adrenomedullin, and smoking pack-years [3]. PhenoAge incorporates markers of immune function, liver function, and metabolic health.
Clinical utility: substantially better. GrimAge acceleration (biological age exceeding chronological age) predicts cardiovascular disease, cancer, and all-cause mortality independently of traditional risk factors.
Third-Generation Clocks (DunedinPACE)
DunedinPACE represents a fundamental shift — instead of estimating a static biological age, it measures the current pace of aging. Developed from the Dunedin longitudinal cohort study, it tracks the rate of decline across 19 biomarkers of organ function measured repeatedly over decades, then identifies the methylation signature associated with faster or slower decline [4].
A DunedinPACE score of 1.0 means you're aging at one year per calendar year (average). A score of 0.85 means you're aging 15% slower. A score of 1.2 means 20% faster.
Clinical utility: highest among epigenetic approaches. DunedinPACE responds to caloric restriction interventions, correlates with physical function measures, and predicts mortality within shorter follow-up windows than static clocks.
Limitations of Epigenetic Testing
Results take 6–12 months to shift meaningfully — not useful for short-term intervention tracking
Sample collection and processing variability can produce noise
Most consumer-facing tests use first-generation clocks that have limited clinical utility
Cost is significant for serial testing
Telomere Length Testing
Telomeres are the protective caps on chromosome ends that shorten with each cell division. Shorter telomeres are associated with cellular senescence, and average telomere length declines with age. The logic seems straightforward — shorter telomeres should indicate older biological age.
The reality is more complicated. Telomere length has high inter-individual variability, is influenced by genetics more than most aging markers, and has weak test-retest reliability in commercial assays. A single telomere length measurement tells you relatively little about your rate of aging or disease risk beyond what standard biomarkers already reveal [5].
When Telomere Testing Adds Value
Detecting extremely short telomeres (below the 10th percentile for age), which are associated with significantly elevated disease risk
Tracking trends over 2+ years with the same assay methodology
Research contexts with large sample sizes where individual measurement noise averages out
When It Doesn't
Single-point measurements for "how old am I really" — the uncertainty band is too wide
Short-term intervention tracking — telomere length doesn't meaningfully change in under 12 months
Comparing results between different testing services — methodological differences make cross-platform comparison unreliable
Blood Biomarker Panels — The Actionable Approach
Blood biomarker panels don't measure "aging" directly — they measure the functional outputs of aging: organ function decline, inflammatory burden, metabolic dysregulation, and hormonal shifts. Composite algorithms like PhenoAge (blood-based version), Levine's phenotypic age, and various commercial aging scores combine these markers into a single biological age estimate.
The advantage of this approach is actionability. Unlike methylation patterns or telomere length, blood biomarkers respond to interventions in weeks to months. You can measure your hsCRP, start an anti-inflammatory protocol, and see measurable improvement at your next blood draw 8–12 weeks later.
Key Longevity Biomarkers
Biomarker | What It Signals | Optimal Range (Longevity) | Responds To |
|---|---|---|---|
Systemic inflammation | < 0.5 mg/L | Diet, exercise, omega-3, sleep | |
Glycemic control | < 5.2% | Diet, exercise, sleep, stress | |
Atherogenic particle count | < 80 mg/dL | Diet, statins, exercise | |
Kidney filtration rate | Age-adjusted, lower is better | Hydration, BP control, metabolic health | |
Liver stress / oxidative burden | < 20 U/L | Alcohol reduction, weight loss | |
Liver synthetic function / nutritional status | 4.5–5.0 g/dL | Nutrition, protein intake | |
Immune aging | > 28% | Exercise, sleep, stress reduction | |
Adrenal reserve / hormonal aging | Upper half of age range | Sleep, stress management, exercise |
These markers collectively capture cardiovascular risk, metabolic health, immune aging, liver function, and hormonal status — the systems that drive most age-related disease and functional decline.
Limitations
No single blood panel captures all dimensions of aging (e.g., brain aging, musculoskeletal aging)
Acute illness, medication changes, or recent intense exercise can temporarily distort results
Composite scoring algorithms vary widely — different formulas applied to the same blood results can produce different "biological ages"
Glycan Analysis
GlycanAge measures the glycosylation patterns of immunoglobulin G (IgG) — the sugar structures attached to antibodies. These patterns shift predictably with age and inflammation status, and they respond to lifestyle interventions faster than epigenetic clocks [6].
The science is legitimate — IgG glycosylation correlates with inflammatory status, immune function, and age-related disease risk. The practical limitation is that glycan analysis captures primarily immune and inflammatory aging. It doesn't assess metabolic health, cardiovascular risk, or organ function independently.
Best use case: as a complement to blood biomarkers, particularly for people focused on inflammation reduction who want a biologically meaningful tracking metric.
Composite and Multi-Omic Approaches
The most comprehensive biological age assessments combine multiple data streams — blood biomarkers, epigenetic data, metabolomics, proteomics, and sometimes functional measures like grip strength, VO₂ max, or cognitive testing.
These approaches produce the richest aging profiles but come with trade-offs: higher cost, greater complexity in interpretation, and the challenge of determining which component is driving the overall score.
For most people optimizing their health, a well-designed blood biomarker panel provides 80% of the actionable signal at 20% of the cost of multi-omic approaches.
How to Choose Your Testing Strategy
Tier 1 — Start Here (Most People)
Comprehensive blood biomarker panel covering inflammation, metabolic health, cardiovascular risk, liver function, kidney function, and hormonal markers. This is the most cost-effective approach with the fastest feedback loop for intervention tracking.
Test every 3–6 months to establish trends and measure intervention response.
Tier 2 — Add Depth
Once blood biomarkers are optimized or you want a deeper aging signal, add an epigenetic clock test — preferably one offering DunedinPACE or GrimAge2. Test annually.
Tier 3 — Full Picture
Combine blood biomarkers (quarterly) with annual epigenetic testing and functional assessments (grip strength, VO₂ max testing, cognitive performance). This provides the broadest aging assessment available outside of research settings.
Track Your Biological Age With Precision
Mito Health tests over 70 biomarkers relevant to aging, including hsCRP, HbA1c, ApoB, cystatin C, DHEA-S, and hormonal panels — with physician-guided interpretation that connects the dots between individual markers and your overall aging trajectory. Individual testing starts at $349 and duo testing starts at $668.
Expected Timelines — When Results Change
Intervention | Blood Biomarkers | Epigenetic Clocks | Telomere Length |
|---|---|---|---|
Anti-inflammatory diet | 4–8 weeks | 6–12 months | 12+ months |
Regular exercise (150+ min/week) | 4–12 weeks | 6–12 months | 12–24 months |
Sleep optimization (7–9 hrs) | 2–6 weeks | 6–12 months | Unknown |
8–12 weeks | 6–12 months | 12+ months | |
Weight loss (5–10% body weight) | 4–12 weeks | 6–12 months | 12–24 months |
Stress reduction practices | 4–8 weeks | 6–12 months | Unknown |
Blood biomarkers provide the fastest feedback loop. This is why they're the foundation of any practical biological age tracking protocol — you can measure, intervene, and re-measure within a single quarter.
Common Mistakes
Taking a single biological age test result as definitive. All methods have uncertainty ranges. A biological age of 42 from one test doesn't mean you're biologically 42 — it means you're somewhere in a range around 42. Track trends, not single numbers.
Comparing results across different platforms. A GrimAge result and a blood biomarker composite score are measuring different things. They're not interchangeable.
Chasing the number instead of optimizing the inputs. Biological age is an output measure. Focus on improving the underlying drivers — inflammation, metabolic health, body composition, sleep, cardiovascular fitness — and the number follows.
Testing too frequently with epigenetic clocks. Methylation changes slowly. Testing more than once per year wastes money and produces noise that looks like signal.
Ignoring functional measures. Grip strength, VO₂ max, balance, and cognitive processing speed are powerful predictors of longevity that no blood test or DNA test captures [7].
Key Takeaways
Biological age tests measure different aspects of aging — no single test captures the full picture
Epigenetic clocks (especially DunedinPACE and GrimAge2) are the most scientifically validated single measure of aging rate
Blood biomarker panels offer the highest actionability — results shift in weeks to months, enabling rapid intervention tracking
Telomere length testing has limited clinical utility for individual health decisions due to high variability
The most practical strategy for most people: quarterly blood biomarker panels as the foundation, with optional annual epigenetic testing for deeper signal
Track trends over time rather than reacting to any single test result
Functional fitness measures (VO₂ max, grip strength) complement lab-based biological age testing and independently predict longevity
Know Your Biological Age
Mito Health tests 100+ biomarkers including epigenetic markers, telomere length proxies, inflammation, and metabolic health with physician-guided interpretation. Measure your true biological age and track your progress over time.
Medical Disclaimer
This guide is for educational purposes only and does not constitute medical advice. Biological age testing results should be interpreted in the context of your complete health history with guidance from a qualified healthcare provider. Do not make treatment decisions based solely on biological age test results. Individual variation in aging biomarkers is substantial — work with a physician who understands longevity medicine to design an appropriate testing and intervention strategy.
Track Your Progress
Monitor the biomarkers that drive biological age with regular testing:
Inflammation markers — hsCRP, IL-6, fibrinogen
Metabolic health — HbA1c, fasting glucose, insulin
Cardiovascular risk — ApoB, Lp(a), lipid panel
Hormonal aging — DHEA-S, testosterone, thyroid panel
Kidney function — cystatin C, eGFR
Related Content
How to Lower CRP and Chronic Inflammation: 8 Evidence-Based Methods
How to Raise Your Omega-3 Index Fast: 7 Evidence-Based Methods
References
Jylhävä J, Pedersen NL, Hägg S. Biological Age Predictors. EBioMedicine. 2017;21:29-36. doi:10.1016/j.ebiom.2017.03.046. PMID: [28396265](https://pubmed.ncbi.nlm.nih.gov/28396265/)
Horvath S. DNA methylation age of human tissues and cell types. Genome Biology. 2013;14(10):R115. doi:10.1186/gb-2013-14-10-r115. PMID: [24138928](https://pubmed.ncbi.nlm.nih.gov/24138928/)
Lu AT, Quach A, Wilson JG, et al. DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging. 2019;11(2):303-327. doi:10.18632/aging.101684. PMID: [30669119](https://pubmed.ncbi.nlm.nih.gov/30669119/)
Belsky DW, Caspi A, Corcoran DL, et al. DunedinPACE, a DNA methylation biomarker of the pace of aging. eLife. 2022;11:e73420. doi:10.7554/eLife.73420. PMID: [35029144](https://pubmed.ncbi.nlm.nih.gov/35029144/)
Blackburn EH, Epel ES, Lin J. Human telomere biology: A contributory and interactive factor in aging, disease risks, and protection. Science. 2015;350(6265):1193-1198. doi:10.1126/science.aab3389. PMID: [26785477](https://pubmed.ncbi.nlm.nih.gov/26785477/)
Gudelj I, Lauc G, Pezer M. Immunoglobulin G glycosylation in aging and diseases. Cell Immunol. 2018;333:65-79. doi:10.1016/j.cellimm.2018.07.009. PMID: [30107893](https://pubmed.ncbi.nlm.nih.gov/30107893/)
Leong DP, Teo KK, Rangarajan S, et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet. 2015;386(9990):266-273. doi:10.1016/S0140-6736(14)62000-6. PMID: [25982160](https://pubmed.ncbi.nlm.nih.gov/25982160/)
Get a deeper look into your health.
Schedule online, results in a week
Clear guidance, follow-up care available
HSA/FSA Eligible
Comments
Get a deeper look into your health.
Schedule online, results in a week
Clear guidance, follow-up care available
HSA/FSA Eligible
Biological Age Tests Compared: Which Method Actually Measures How Fast You're Aging?
Compare the 5 main biological age testing methods — epigenetic clocks, telomere length, blood biomarker panels, glycan analysis, and composite algorithms — by accuracy, cost, actionability, and what each actually measures. Includes optimal ranges and how to track your rate of aging over time.
Written by
Mito Health
Quick Summary
Compare the 5 main biological age testing methods — epigenetic clocks, telomere length, blood biomarker panels, glycan analysis, and composite algorithms — by accuracy, cost, actionability, and what each actually measures. Includes how to interpret results, which markers respond to intervention, and how to track your rate of aging over time.
You're 38 years old. A DNA methylation test says your biological age is 44. A blood biomarker algorithm says it's 33. Your telomere test came back "average for your age." You now have three numbers, three different methodologies, and no clear idea whether you're aging faster or slower than you should be.
This is the core problem with biological age testing in 2026 — there are at least five fundamentally different approaches, each measuring different aspects of the aging process, and they frequently disagree with each other. A person can have "young" epigenetic age and "old" telomeres simultaneously, because these tests aren't measuring the same thing. They're measuring different biological systems that age at different rates in different people.
The other issue — most biological age tests produce a single number that feels precise but obscures enormous uncertainty. An epigenetic clock that reports your age as 41.3 has a standard error of ±3–5 years. A telomere test that says you're "younger than average" tells you almost nothing about disease risk or how your body will respond to a specific intervention. The marketing around these tests is far more confident than the science supports.
This guide compares the five main biological age testing methods — what each actually measures, how accurate it is, how actionable the result is, and which approach gives you the most useful signal for tracking whether your longevity interventions are working.
Quick Decision Tree — Choose Your Biological Age Test in 30 Seconds
Want the most scientifically validated single measure of aging? Third-generation epigenetic clock (GrimAge2, DunedinPACE)
Want actionable markers you can improve in 3–6 months? Blood biomarker panel with composite scoring
Want to track rate of aging rather than a static age estimate? DunedinPACE (pace-of-aging clock)
On a budget and want a practical starting point? Comprehensive blood panel with longevity-relevant markers
Want the broadest aging picture? Combine blood biomarkers with an epigenetic clock annually
What Is Biological Age?
Biological age is a measure of how much physiological deterioration has occurred in your body relative to the average person of your chronological age. Two 45-year-olds can have dramatically different rates of organ function decline, disease risk, and cellular damage — biological age attempts to quantify that difference.
The concept is clinically meaningful. Research consistently shows that biological age predicts mortality, cardiovascular events, cancer incidence, and cognitive decline more accurately than chronological age alone [1]. The practical question isn't whether biological age matters — it's which measurement approach captures the most useful information.
There's an important distinction most testing companies gloss over: biological age (a static estimate of your cumulative aging) versus pace of aging (how fast you're currently aging). A 40-year-old with a biological age of 35 might still be aging faster than average right now. The static number tells you where you are. The pace tells you where you're heading. Both matter, but they require different measurement approaches.
The 5 Methods — At-a-Glance Comparison
Method | What It Measures | Accuracy (Test-Retest) | Actionability | Cost Range | Time to See Change |
|---|---|---|---|---|---|
Epigenetic Clocks (DNA Methylation) | CpG site methylation patterns across the genome | High (±2–4 years) | Moderate — slow to change | $200–$500 | 6–12 months |
Telomere Length | Terminal chromosome cap length | Low-Moderate (high variability) | Low — poor intervention sensitivity | $100–$300 | 12–24+ months |
Blood Biomarker Panels | Organ function, inflammation, metabolic health markers | Moderate-High (marker-dependent) | High — responds to lifestyle in weeks | $100–$500 | 4–12 weeks |
Glycan Analysis (GlycanAge) | IgG glycosylation patterns | Moderate (±3–5 years) | Moderate — responds to lifestyle in months | $300–$500 | 3–6 months |
Composite Algorithms | Multi-omic or multi-biomarker weighted scores | Varies by algorithm | High — combines multiple signals | $300–$1,000+ | Depends on inputs |
Epigenetic Clocks — DNA Methylation Testing
Epigenetic clocks are the most scientifically validated approach to biological age estimation. They work by analyzing DNA methylation patterns at specific CpG sites — chemical modifications that change predictably with age and are influenced by environmental exposures, lifestyle, and disease states [2].
Not all epigenetic clocks are equal. The field has gone through three generations, and the differences matter enormously for interpretation.
First-Generation Clocks (Horvath, Hannum)
These clocks were trained to predict chronological age from methylation data. They do this well — Horvath's multi-tissue clock achieves a correlation of r = 0.96 with chronological age across thousands of samples. The problem is that a clock trained to predict chronological age doesn't necessarily capture biological aging. Someone aging rapidly and someone aging slowly can produce similar readings if their methylation patterns happen to track chronological time rather than physiological decline.
Clinical utility: limited. These clocks detect large deviations from expected aging but lack sensitivity to lifestyle interventions.
Second-Generation Clocks (PhenoAge, GrimAge)
These clocks were trained to predict mortality and disease outcomes rather than chronological age. GrimAge, developed by Ake Lu and Steve Horvath, incorporates DNA methylation surrogates for plasma proteins associated with mortality — including PAI-1, adrenomedullin, and smoking pack-years [3]. PhenoAge incorporates markers of immune function, liver function, and metabolic health.
Clinical utility: substantially better. GrimAge acceleration (biological age exceeding chronological age) predicts cardiovascular disease, cancer, and all-cause mortality independently of traditional risk factors.
Third-Generation Clocks (DunedinPACE)
DunedinPACE represents a fundamental shift — instead of estimating a static biological age, it measures the current pace of aging. Developed from the Dunedin longitudinal cohort study, it tracks the rate of decline across 19 biomarkers of organ function measured repeatedly over decades, then identifies the methylation signature associated with faster or slower decline [4].
A DunedinPACE score of 1.0 means you're aging at one year per calendar year (average). A score of 0.85 means you're aging 15% slower. A score of 1.2 means 20% faster.
Clinical utility: highest among epigenetic approaches. DunedinPACE responds to caloric restriction interventions, correlates with physical function measures, and predicts mortality within shorter follow-up windows than static clocks.
Limitations of Epigenetic Testing
Results take 6–12 months to shift meaningfully — not useful for short-term intervention tracking
Sample collection and processing variability can produce noise
Most consumer-facing tests use first-generation clocks that have limited clinical utility
Cost is significant for serial testing
Telomere Length Testing
Telomeres are the protective caps on chromosome ends that shorten with each cell division. Shorter telomeres are associated with cellular senescence, and average telomere length declines with age. The logic seems straightforward — shorter telomeres should indicate older biological age.
The reality is more complicated. Telomere length has high inter-individual variability, is influenced by genetics more than most aging markers, and has weak test-retest reliability in commercial assays. A single telomere length measurement tells you relatively little about your rate of aging or disease risk beyond what standard biomarkers already reveal [5].
When Telomere Testing Adds Value
Detecting extremely short telomeres (below the 10th percentile for age), which are associated with significantly elevated disease risk
Tracking trends over 2+ years with the same assay methodology
Research contexts with large sample sizes where individual measurement noise averages out
When It Doesn't
Single-point measurements for "how old am I really" — the uncertainty band is too wide
Short-term intervention tracking — telomere length doesn't meaningfully change in under 12 months
Comparing results between different testing services — methodological differences make cross-platform comparison unreliable
Blood Biomarker Panels — The Actionable Approach
Blood biomarker panels don't measure "aging" directly — they measure the functional outputs of aging: organ function decline, inflammatory burden, metabolic dysregulation, and hormonal shifts. Composite algorithms like PhenoAge (blood-based version), Levine's phenotypic age, and various commercial aging scores combine these markers into a single biological age estimate.
The advantage of this approach is actionability. Unlike methylation patterns or telomere length, blood biomarkers respond to interventions in weeks to months. You can measure your hsCRP, start an anti-inflammatory protocol, and see measurable improvement at your next blood draw 8–12 weeks later.
Key Longevity Biomarkers
Biomarker | What It Signals | Optimal Range (Longevity) | Responds To |
|---|---|---|---|
Systemic inflammation | < 0.5 mg/L | Diet, exercise, omega-3, sleep | |
Glycemic control | < 5.2% | Diet, exercise, sleep, stress | |
Atherogenic particle count | < 80 mg/dL | Diet, statins, exercise | |
Kidney filtration rate | Age-adjusted, lower is better | Hydration, BP control, metabolic health | |
Liver stress / oxidative burden | < 20 U/L | Alcohol reduction, weight loss | |
Liver synthetic function / nutritional status | 4.5–5.0 g/dL | Nutrition, protein intake | |
Immune aging | > 28% | Exercise, sleep, stress reduction | |
Adrenal reserve / hormonal aging | Upper half of age range | Sleep, stress management, exercise |
These markers collectively capture cardiovascular risk, metabolic health, immune aging, liver function, and hormonal status — the systems that drive most age-related disease and functional decline.
Limitations
No single blood panel captures all dimensions of aging (e.g., brain aging, musculoskeletal aging)
Acute illness, medication changes, or recent intense exercise can temporarily distort results
Composite scoring algorithms vary widely — different formulas applied to the same blood results can produce different "biological ages"
Glycan Analysis
GlycanAge measures the glycosylation patterns of immunoglobulin G (IgG) — the sugar structures attached to antibodies. These patterns shift predictably with age and inflammation status, and they respond to lifestyle interventions faster than epigenetic clocks [6].
The science is legitimate — IgG glycosylation correlates with inflammatory status, immune function, and age-related disease risk. The practical limitation is that glycan analysis captures primarily immune and inflammatory aging. It doesn't assess metabolic health, cardiovascular risk, or organ function independently.
Best use case: as a complement to blood biomarkers, particularly for people focused on inflammation reduction who want a biologically meaningful tracking metric.
Composite and Multi-Omic Approaches
The most comprehensive biological age assessments combine multiple data streams — blood biomarkers, epigenetic data, metabolomics, proteomics, and sometimes functional measures like grip strength, VO₂ max, or cognitive testing.
These approaches produce the richest aging profiles but come with trade-offs: higher cost, greater complexity in interpretation, and the challenge of determining which component is driving the overall score.
For most people optimizing their health, a well-designed blood biomarker panel provides 80% of the actionable signal at 20% of the cost of multi-omic approaches.
How to Choose Your Testing Strategy
Tier 1 — Start Here (Most People)
Comprehensive blood biomarker panel covering inflammation, metabolic health, cardiovascular risk, liver function, kidney function, and hormonal markers. This is the most cost-effective approach with the fastest feedback loop for intervention tracking.
Test every 3–6 months to establish trends and measure intervention response.
Tier 2 — Add Depth
Once blood biomarkers are optimized or you want a deeper aging signal, add an epigenetic clock test — preferably one offering DunedinPACE or GrimAge2. Test annually.
Tier 3 — Full Picture
Combine blood biomarkers (quarterly) with annual epigenetic testing and functional assessments (grip strength, VO₂ max testing, cognitive performance). This provides the broadest aging assessment available outside of research settings.
Track Your Biological Age With Precision
Mito Health tests over 70 biomarkers relevant to aging, including hsCRP, HbA1c, ApoB, cystatin C, DHEA-S, and hormonal panels — with physician-guided interpretation that connects the dots between individual markers and your overall aging trajectory. Individual testing starts at $349 and duo testing starts at $668.
Expected Timelines — When Results Change
Intervention | Blood Biomarkers | Epigenetic Clocks | Telomere Length |
|---|---|---|---|
Anti-inflammatory diet | 4–8 weeks | 6–12 months | 12+ months |
Regular exercise (150+ min/week) | 4–12 weeks | 6–12 months | 12–24 months |
Sleep optimization (7–9 hrs) | 2–6 weeks | 6–12 months | Unknown |
8–12 weeks | 6–12 months | 12+ months | |
Weight loss (5–10% body weight) | 4–12 weeks | 6–12 months | 12–24 months |
Stress reduction practices | 4–8 weeks | 6–12 months | Unknown |
Blood biomarkers provide the fastest feedback loop. This is why they're the foundation of any practical biological age tracking protocol — you can measure, intervene, and re-measure within a single quarter.
Common Mistakes
Taking a single biological age test result as definitive. All methods have uncertainty ranges. A biological age of 42 from one test doesn't mean you're biologically 42 — it means you're somewhere in a range around 42. Track trends, not single numbers.
Comparing results across different platforms. A GrimAge result and a blood biomarker composite score are measuring different things. They're not interchangeable.
Chasing the number instead of optimizing the inputs. Biological age is an output measure. Focus on improving the underlying drivers — inflammation, metabolic health, body composition, sleep, cardiovascular fitness — and the number follows.
Testing too frequently with epigenetic clocks. Methylation changes slowly. Testing more than once per year wastes money and produces noise that looks like signal.
Ignoring functional measures. Grip strength, VO₂ max, balance, and cognitive processing speed are powerful predictors of longevity that no blood test or DNA test captures [7].
Key Takeaways
Biological age tests measure different aspects of aging — no single test captures the full picture
Epigenetic clocks (especially DunedinPACE and GrimAge2) are the most scientifically validated single measure of aging rate
Blood biomarker panels offer the highest actionability — results shift in weeks to months, enabling rapid intervention tracking
Telomere length testing has limited clinical utility for individual health decisions due to high variability
The most practical strategy for most people: quarterly blood biomarker panels as the foundation, with optional annual epigenetic testing for deeper signal
Track trends over time rather than reacting to any single test result
Functional fitness measures (VO₂ max, grip strength) complement lab-based biological age testing and independently predict longevity
Know Your Biological Age
Mito Health tests 100+ biomarkers including epigenetic markers, telomere length proxies, inflammation, and metabolic health with physician-guided interpretation. Measure your true biological age and track your progress over time.
Medical Disclaimer
This guide is for educational purposes only and does not constitute medical advice. Biological age testing results should be interpreted in the context of your complete health history with guidance from a qualified healthcare provider. Do not make treatment decisions based solely on biological age test results. Individual variation in aging biomarkers is substantial — work with a physician who understands longevity medicine to design an appropriate testing and intervention strategy.
Track Your Progress
Monitor the biomarkers that drive biological age with regular testing:
Inflammation markers — hsCRP, IL-6, fibrinogen
Metabolic health — HbA1c, fasting glucose, insulin
Cardiovascular risk — ApoB, Lp(a), lipid panel
Hormonal aging — DHEA-S, testosterone, thyroid panel
Kidney function — cystatin C, eGFR
Related Content
How to Lower CRP and Chronic Inflammation: 8 Evidence-Based Methods
How to Raise Your Omega-3 Index Fast: 7 Evidence-Based Methods
References
Jylhävä J, Pedersen NL, Hägg S. Biological Age Predictors. EBioMedicine. 2017;21:29-36. doi:10.1016/j.ebiom.2017.03.046. PMID: [28396265](https://pubmed.ncbi.nlm.nih.gov/28396265/)
Horvath S. DNA methylation age of human tissues and cell types. Genome Biology. 2013;14(10):R115. doi:10.1186/gb-2013-14-10-r115. PMID: [24138928](https://pubmed.ncbi.nlm.nih.gov/24138928/)
Lu AT, Quach A, Wilson JG, et al. DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging. 2019;11(2):303-327. doi:10.18632/aging.101684. PMID: [30669119](https://pubmed.ncbi.nlm.nih.gov/30669119/)
Belsky DW, Caspi A, Corcoran DL, et al. DunedinPACE, a DNA methylation biomarker of the pace of aging. eLife. 2022;11:e73420. doi:10.7554/eLife.73420. PMID: [35029144](https://pubmed.ncbi.nlm.nih.gov/35029144/)
Blackburn EH, Epel ES, Lin J. Human telomere biology: A contributory and interactive factor in aging, disease risks, and protection. Science. 2015;350(6265):1193-1198. doi:10.1126/science.aab3389. PMID: [26785477](https://pubmed.ncbi.nlm.nih.gov/26785477/)
Gudelj I, Lauc G, Pezer M. Immunoglobulin G glycosylation in aging and diseases. Cell Immunol. 2018;333:65-79. doi:10.1016/j.cellimm.2018.07.009. PMID: [30107893](https://pubmed.ncbi.nlm.nih.gov/30107893/)
Leong DP, Teo KK, Rangarajan S, et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet. 2015;386(9990):266-273. doi:10.1016/S0140-6736(14)62000-6. PMID: [25982160](https://pubmed.ncbi.nlm.nih.gov/25982160/)
Get a deeper look into your health.
Schedule online, results in a week
Clear guidance, follow-up care available
HSA/FSA Eligible
Comments
Biological Age Tests Compared: Which Method Actually Measures How Fast You're Aging?
Compare the 5 main biological age testing methods — epigenetic clocks, telomere length, blood biomarker panels, glycan analysis, and composite algorithms — by accuracy, cost, actionability, and what each actually measures. Includes optimal ranges and how to track your rate of aging over time.
Written by
Mito Health
Quick Summary
Compare the 5 main biological age testing methods — epigenetic clocks, telomere length, blood biomarker panels, glycan analysis, and composite algorithms — by accuracy, cost, actionability, and what each actually measures. Includes how to interpret results, which markers respond to intervention, and how to track your rate of aging over time.
You're 38 years old. A DNA methylation test says your biological age is 44. A blood biomarker algorithm says it's 33. Your telomere test came back "average for your age." You now have three numbers, three different methodologies, and no clear idea whether you're aging faster or slower than you should be.
This is the core problem with biological age testing in 2026 — there are at least five fundamentally different approaches, each measuring different aspects of the aging process, and they frequently disagree with each other. A person can have "young" epigenetic age and "old" telomeres simultaneously, because these tests aren't measuring the same thing. They're measuring different biological systems that age at different rates in different people.
The other issue — most biological age tests produce a single number that feels precise but obscures enormous uncertainty. An epigenetic clock that reports your age as 41.3 has a standard error of ±3–5 years. A telomere test that says you're "younger than average" tells you almost nothing about disease risk or how your body will respond to a specific intervention. The marketing around these tests is far more confident than the science supports.
This guide compares the five main biological age testing methods — what each actually measures, how accurate it is, how actionable the result is, and which approach gives you the most useful signal for tracking whether your longevity interventions are working.
Quick Decision Tree — Choose Your Biological Age Test in 30 Seconds
Want the most scientifically validated single measure of aging? Third-generation epigenetic clock (GrimAge2, DunedinPACE)
Want actionable markers you can improve in 3–6 months? Blood biomarker panel with composite scoring
Want to track rate of aging rather than a static age estimate? DunedinPACE (pace-of-aging clock)
On a budget and want a practical starting point? Comprehensive blood panel with longevity-relevant markers
Want the broadest aging picture? Combine blood biomarkers with an epigenetic clock annually
What Is Biological Age?
Biological age is a measure of how much physiological deterioration has occurred in your body relative to the average person of your chronological age. Two 45-year-olds can have dramatically different rates of organ function decline, disease risk, and cellular damage — biological age attempts to quantify that difference.
The concept is clinically meaningful. Research consistently shows that biological age predicts mortality, cardiovascular events, cancer incidence, and cognitive decline more accurately than chronological age alone [1]. The practical question isn't whether biological age matters — it's which measurement approach captures the most useful information.
There's an important distinction most testing companies gloss over: biological age (a static estimate of your cumulative aging) versus pace of aging (how fast you're currently aging). A 40-year-old with a biological age of 35 might still be aging faster than average right now. The static number tells you where you are. The pace tells you where you're heading. Both matter, but they require different measurement approaches.
The 5 Methods — At-a-Glance Comparison
Method | What It Measures | Accuracy (Test-Retest) | Actionability | Cost Range | Time to See Change |
|---|---|---|---|---|---|
Epigenetic Clocks (DNA Methylation) | CpG site methylation patterns across the genome | High (±2–4 years) | Moderate — slow to change | $200–$500 | 6–12 months |
Telomere Length | Terminal chromosome cap length | Low-Moderate (high variability) | Low — poor intervention sensitivity | $100–$300 | 12–24+ months |
Blood Biomarker Panels | Organ function, inflammation, metabolic health markers | Moderate-High (marker-dependent) | High — responds to lifestyle in weeks | $100–$500 | 4–12 weeks |
Glycan Analysis (GlycanAge) | IgG glycosylation patterns | Moderate (±3–5 years) | Moderate — responds to lifestyle in months | $300–$500 | 3–6 months |
Composite Algorithms | Multi-omic or multi-biomarker weighted scores | Varies by algorithm | High — combines multiple signals | $300–$1,000+ | Depends on inputs |
Epigenetic Clocks — DNA Methylation Testing
Epigenetic clocks are the most scientifically validated approach to biological age estimation. They work by analyzing DNA methylation patterns at specific CpG sites — chemical modifications that change predictably with age and are influenced by environmental exposures, lifestyle, and disease states [2].
Not all epigenetic clocks are equal. The field has gone through three generations, and the differences matter enormously for interpretation.
First-Generation Clocks (Horvath, Hannum)
These clocks were trained to predict chronological age from methylation data. They do this well — Horvath's multi-tissue clock achieves a correlation of r = 0.96 with chronological age across thousands of samples. The problem is that a clock trained to predict chronological age doesn't necessarily capture biological aging. Someone aging rapidly and someone aging slowly can produce similar readings if their methylation patterns happen to track chronological time rather than physiological decline.
Clinical utility: limited. These clocks detect large deviations from expected aging but lack sensitivity to lifestyle interventions.
Second-Generation Clocks (PhenoAge, GrimAge)
These clocks were trained to predict mortality and disease outcomes rather than chronological age. GrimAge, developed by Ake Lu and Steve Horvath, incorporates DNA methylation surrogates for plasma proteins associated with mortality — including PAI-1, adrenomedullin, and smoking pack-years [3]. PhenoAge incorporates markers of immune function, liver function, and metabolic health.
Clinical utility: substantially better. GrimAge acceleration (biological age exceeding chronological age) predicts cardiovascular disease, cancer, and all-cause mortality independently of traditional risk factors.
Third-Generation Clocks (DunedinPACE)
DunedinPACE represents a fundamental shift — instead of estimating a static biological age, it measures the current pace of aging. Developed from the Dunedin longitudinal cohort study, it tracks the rate of decline across 19 biomarkers of organ function measured repeatedly over decades, then identifies the methylation signature associated with faster or slower decline [4].
A DunedinPACE score of 1.0 means you're aging at one year per calendar year (average). A score of 0.85 means you're aging 15% slower. A score of 1.2 means 20% faster.
Clinical utility: highest among epigenetic approaches. DunedinPACE responds to caloric restriction interventions, correlates with physical function measures, and predicts mortality within shorter follow-up windows than static clocks.
Limitations of Epigenetic Testing
Results take 6–12 months to shift meaningfully — not useful for short-term intervention tracking
Sample collection and processing variability can produce noise
Most consumer-facing tests use first-generation clocks that have limited clinical utility
Cost is significant for serial testing
Telomere Length Testing
Telomeres are the protective caps on chromosome ends that shorten with each cell division. Shorter telomeres are associated with cellular senescence, and average telomere length declines with age. The logic seems straightforward — shorter telomeres should indicate older biological age.
The reality is more complicated. Telomere length has high inter-individual variability, is influenced by genetics more than most aging markers, and has weak test-retest reliability in commercial assays. A single telomere length measurement tells you relatively little about your rate of aging or disease risk beyond what standard biomarkers already reveal [5].
When Telomere Testing Adds Value
Detecting extremely short telomeres (below the 10th percentile for age), which are associated with significantly elevated disease risk
Tracking trends over 2+ years with the same assay methodology
Research contexts with large sample sizes where individual measurement noise averages out
When It Doesn't
Single-point measurements for "how old am I really" — the uncertainty band is too wide
Short-term intervention tracking — telomere length doesn't meaningfully change in under 12 months
Comparing results between different testing services — methodological differences make cross-platform comparison unreliable
Blood Biomarker Panels — The Actionable Approach
Blood biomarker panels don't measure "aging" directly — they measure the functional outputs of aging: organ function decline, inflammatory burden, metabolic dysregulation, and hormonal shifts. Composite algorithms like PhenoAge (blood-based version), Levine's phenotypic age, and various commercial aging scores combine these markers into a single biological age estimate.
The advantage of this approach is actionability. Unlike methylation patterns or telomere length, blood biomarkers respond to interventions in weeks to months. You can measure your hsCRP, start an anti-inflammatory protocol, and see measurable improvement at your next blood draw 8–12 weeks later.
Key Longevity Biomarkers
Biomarker | What It Signals | Optimal Range (Longevity) | Responds To |
|---|---|---|---|
Systemic inflammation | < 0.5 mg/L | Diet, exercise, omega-3, sleep | |
Glycemic control | < 5.2% | Diet, exercise, sleep, stress | |
Atherogenic particle count | < 80 mg/dL | Diet, statins, exercise | |
Kidney filtration rate | Age-adjusted, lower is better | Hydration, BP control, metabolic health | |
Liver stress / oxidative burden | < 20 U/L | Alcohol reduction, weight loss | |
Liver synthetic function / nutritional status | 4.5–5.0 g/dL | Nutrition, protein intake | |
Immune aging | > 28% | Exercise, sleep, stress reduction | |
Adrenal reserve / hormonal aging | Upper half of age range | Sleep, stress management, exercise |
These markers collectively capture cardiovascular risk, metabolic health, immune aging, liver function, and hormonal status — the systems that drive most age-related disease and functional decline.
Limitations
No single blood panel captures all dimensions of aging (e.g., brain aging, musculoskeletal aging)
Acute illness, medication changes, or recent intense exercise can temporarily distort results
Composite scoring algorithms vary widely — different formulas applied to the same blood results can produce different "biological ages"
Glycan Analysis
GlycanAge measures the glycosylation patterns of immunoglobulin G (IgG) — the sugar structures attached to antibodies. These patterns shift predictably with age and inflammation status, and they respond to lifestyle interventions faster than epigenetic clocks [6].
The science is legitimate — IgG glycosylation correlates with inflammatory status, immune function, and age-related disease risk. The practical limitation is that glycan analysis captures primarily immune and inflammatory aging. It doesn't assess metabolic health, cardiovascular risk, or organ function independently.
Best use case: as a complement to blood biomarkers, particularly for people focused on inflammation reduction who want a biologically meaningful tracking metric.
Composite and Multi-Omic Approaches
The most comprehensive biological age assessments combine multiple data streams — blood biomarkers, epigenetic data, metabolomics, proteomics, and sometimes functional measures like grip strength, VO₂ max, or cognitive testing.
These approaches produce the richest aging profiles but come with trade-offs: higher cost, greater complexity in interpretation, and the challenge of determining which component is driving the overall score.
For most people optimizing their health, a well-designed blood biomarker panel provides 80% of the actionable signal at 20% of the cost of multi-omic approaches.
How to Choose Your Testing Strategy
Tier 1 — Start Here (Most People)
Comprehensive blood biomarker panel covering inflammation, metabolic health, cardiovascular risk, liver function, kidney function, and hormonal markers. This is the most cost-effective approach with the fastest feedback loop for intervention tracking.
Test every 3–6 months to establish trends and measure intervention response.
Tier 2 — Add Depth
Once blood biomarkers are optimized or you want a deeper aging signal, add an epigenetic clock test — preferably one offering DunedinPACE or GrimAge2. Test annually.
Tier 3 — Full Picture
Combine blood biomarkers (quarterly) with annual epigenetic testing and functional assessments (grip strength, VO₂ max testing, cognitive performance). This provides the broadest aging assessment available outside of research settings.
Track Your Biological Age With Precision
Mito Health tests over 70 biomarkers relevant to aging, including hsCRP, HbA1c, ApoB, cystatin C, DHEA-S, and hormonal panels — with physician-guided interpretation that connects the dots between individual markers and your overall aging trajectory. Individual testing starts at $349 and duo testing starts at $668.
Expected Timelines — When Results Change
Intervention | Blood Biomarkers | Epigenetic Clocks | Telomere Length |
|---|---|---|---|
Anti-inflammatory diet | 4–8 weeks | 6–12 months | 12+ months |
Regular exercise (150+ min/week) | 4–12 weeks | 6–12 months | 12–24 months |
Sleep optimization (7–9 hrs) | 2–6 weeks | 6–12 months | Unknown |
8–12 weeks | 6–12 months | 12+ months | |
Weight loss (5–10% body weight) | 4–12 weeks | 6–12 months | 12–24 months |
Stress reduction practices | 4–8 weeks | 6–12 months | Unknown |
Blood biomarkers provide the fastest feedback loop. This is why they're the foundation of any practical biological age tracking protocol — you can measure, intervene, and re-measure within a single quarter.
Common Mistakes
Taking a single biological age test result as definitive. All methods have uncertainty ranges. A biological age of 42 from one test doesn't mean you're biologically 42 — it means you're somewhere in a range around 42. Track trends, not single numbers.
Comparing results across different platforms. A GrimAge result and a blood biomarker composite score are measuring different things. They're not interchangeable.
Chasing the number instead of optimizing the inputs. Biological age is an output measure. Focus on improving the underlying drivers — inflammation, metabolic health, body composition, sleep, cardiovascular fitness — and the number follows.
Testing too frequently with epigenetic clocks. Methylation changes slowly. Testing more than once per year wastes money and produces noise that looks like signal.
Ignoring functional measures. Grip strength, VO₂ max, balance, and cognitive processing speed are powerful predictors of longevity that no blood test or DNA test captures [7].
Key Takeaways
Biological age tests measure different aspects of aging — no single test captures the full picture
Epigenetic clocks (especially DunedinPACE and GrimAge2) are the most scientifically validated single measure of aging rate
Blood biomarker panels offer the highest actionability — results shift in weeks to months, enabling rapid intervention tracking
Telomere length testing has limited clinical utility for individual health decisions due to high variability
The most practical strategy for most people: quarterly blood biomarker panels as the foundation, with optional annual epigenetic testing for deeper signal
Track trends over time rather than reacting to any single test result
Functional fitness measures (VO₂ max, grip strength) complement lab-based biological age testing and independently predict longevity
Know Your Biological Age
Mito Health tests 100+ biomarkers including epigenetic markers, telomere length proxies, inflammation, and metabolic health with physician-guided interpretation. Measure your true biological age and track your progress over time.
Medical Disclaimer
This guide is for educational purposes only and does not constitute medical advice. Biological age testing results should be interpreted in the context of your complete health history with guidance from a qualified healthcare provider. Do not make treatment decisions based solely on biological age test results. Individual variation in aging biomarkers is substantial — work with a physician who understands longevity medicine to design an appropriate testing and intervention strategy.
Track Your Progress
Monitor the biomarkers that drive biological age with regular testing:
Inflammation markers — hsCRP, IL-6, fibrinogen
Metabolic health — HbA1c, fasting glucose, insulin
Cardiovascular risk — ApoB, Lp(a), lipid panel
Hormonal aging — DHEA-S, testosterone, thyroid panel
Kidney function — cystatin C, eGFR
Related Content
How to Lower CRP and Chronic Inflammation: 8 Evidence-Based Methods
How to Raise Your Omega-3 Index Fast: 7 Evidence-Based Methods
References
Jylhävä J, Pedersen NL, Hägg S. Biological Age Predictors. EBioMedicine. 2017;21:29-36. doi:10.1016/j.ebiom.2017.03.046. PMID: [28396265](https://pubmed.ncbi.nlm.nih.gov/28396265/)
Horvath S. DNA methylation age of human tissues and cell types. Genome Biology. 2013;14(10):R115. doi:10.1186/gb-2013-14-10-r115. PMID: [24138928](https://pubmed.ncbi.nlm.nih.gov/24138928/)
Lu AT, Quach A, Wilson JG, et al. DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging. 2019;11(2):303-327. doi:10.18632/aging.101684. PMID: [30669119](https://pubmed.ncbi.nlm.nih.gov/30669119/)
Belsky DW, Caspi A, Corcoran DL, et al. DunedinPACE, a DNA methylation biomarker of the pace of aging. eLife. 2022;11:e73420. doi:10.7554/eLife.73420. PMID: [35029144](https://pubmed.ncbi.nlm.nih.gov/35029144/)
Blackburn EH, Epel ES, Lin J. Human telomere biology: A contributory and interactive factor in aging, disease risks, and protection. Science. 2015;350(6265):1193-1198. doi:10.1126/science.aab3389. PMID: [26785477](https://pubmed.ncbi.nlm.nih.gov/26785477/)
Gudelj I, Lauc G, Pezer M. Immunoglobulin G glycosylation in aging and diseases. Cell Immunol. 2018;333:65-79. doi:10.1016/j.cellimm.2018.07.009. PMID: [30107893](https://pubmed.ncbi.nlm.nih.gov/30107893/)
Leong DP, Teo KK, Rangarajan S, et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet. 2015;386(9990):266-273. doi:10.1016/S0140-6736(14)62000-6. PMID: [25982160](https://pubmed.ncbi.nlm.nih.gov/25982160/)
Get a deeper look into your health.
Schedule online, results in a week
Clear guidance, follow-up care available
HSA/FSA Eligible
Comments
Biological Age Tests Compared: Which Method Actually Measures How Fast You're Aging?
Compare the 5 main biological age testing methods — epigenetic clocks, telomere length, blood biomarker panels, glycan analysis, and composite algorithms — by accuracy, cost, actionability, and what each actually measures. Includes optimal ranges and how to track your rate of aging over time.
Written by
Mito Health
Quick Summary
Compare the 5 main biological age testing methods — epigenetic clocks, telomere length, blood biomarker panels, glycan analysis, and composite algorithms — by accuracy, cost, actionability, and what each actually measures. Includes how to interpret results, which markers respond to intervention, and how to track your rate of aging over time.
You're 38 years old. A DNA methylation test says your biological age is 44. A blood biomarker algorithm says it's 33. Your telomere test came back "average for your age." You now have three numbers, three different methodologies, and no clear idea whether you're aging faster or slower than you should be.
This is the core problem with biological age testing in 2026 — there are at least five fundamentally different approaches, each measuring different aspects of the aging process, and they frequently disagree with each other. A person can have "young" epigenetic age and "old" telomeres simultaneously, because these tests aren't measuring the same thing. They're measuring different biological systems that age at different rates in different people.
The other issue — most biological age tests produce a single number that feels precise but obscures enormous uncertainty. An epigenetic clock that reports your age as 41.3 has a standard error of ±3–5 years. A telomere test that says you're "younger than average" tells you almost nothing about disease risk or how your body will respond to a specific intervention. The marketing around these tests is far more confident than the science supports.
This guide compares the five main biological age testing methods — what each actually measures, how accurate it is, how actionable the result is, and which approach gives you the most useful signal for tracking whether your longevity interventions are working.
Quick Decision Tree — Choose Your Biological Age Test in 30 Seconds
Want the most scientifically validated single measure of aging? Third-generation epigenetic clock (GrimAge2, DunedinPACE)
Want actionable markers you can improve in 3–6 months? Blood biomarker panel with composite scoring
Want to track rate of aging rather than a static age estimate? DunedinPACE (pace-of-aging clock)
On a budget and want a practical starting point? Comprehensive blood panel with longevity-relevant markers
Want the broadest aging picture? Combine blood biomarkers with an epigenetic clock annually
What Is Biological Age?
Biological age is a measure of how much physiological deterioration has occurred in your body relative to the average person of your chronological age. Two 45-year-olds can have dramatically different rates of organ function decline, disease risk, and cellular damage — biological age attempts to quantify that difference.
The concept is clinically meaningful. Research consistently shows that biological age predicts mortality, cardiovascular events, cancer incidence, and cognitive decline more accurately than chronological age alone [1]. The practical question isn't whether biological age matters — it's which measurement approach captures the most useful information.
There's an important distinction most testing companies gloss over: biological age (a static estimate of your cumulative aging) versus pace of aging (how fast you're currently aging). A 40-year-old with a biological age of 35 might still be aging faster than average right now. The static number tells you where you are. The pace tells you where you're heading. Both matter, but they require different measurement approaches.
The 5 Methods — At-a-Glance Comparison
Method | What It Measures | Accuracy (Test-Retest) | Actionability | Cost Range | Time to See Change |
|---|---|---|---|---|---|
Epigenetic Clocks (DNA Methylation) | CpG site methylation patterns across the genome | High (±2–4 years) | Moderate — slow to change | $200–$500 | 6–12 months |
Telomere Length | Terminal chromosome cap length | Low-Moderate (high variability) | Low — poor intervention sensitivity | $100–$300 | 12–24+ months |
Blood Biomarker Panels | Organ function, inflammation, metabolic health markers | Moderate-High (marker-dependent) | High — responds to lifestyle in weeks | $100–$500 | 4–12 weeks |
Glycan Analysis (GlycanAge) | IgG glycosylation patterns | Moderate (±3–5 years) | Moderate — responds to lifestyle in months | $300–$500 | 3–6 months |
Composite Algorithms | Multi-omic or multi-biomarker weighted scores | Varies by algorithm | High — combines multiple signals | $300–$1,000+ | Depends on inputs |
Epigenetic Clocks — DNA Methylation Testing
Epigenetic clocks are the most scientifically validated approach to biological age estimation. They work by analyzing DNA methylation patterns at specific CpG sites — chemical modifications that change predictably with age and are influenced by environmental exposures, lifestyle, and disease states [2].
Not all epigenetic clocks are equal. The field has gone through three generations, and the differences matter enormously for interpretation.
First-Generation Clocks (Horvath, Hannum)
These clocks were trained to predict chronological age from methylation data. They do this well — Horvath's multi-tissue clock achieves a correlation of r = 0.96 with chronological age across thousands of samples. The problem is that a clock trained to predict chronological age doesn't necessarily capture biological aging. Someone aging rapidly and someone aging slowly can produce similar readings if their methylation patterns happen to track chronological time rather than physiological decline.
Clinical utility: limited. These clocks detect large deviations from expected aging but lack sensitivity to lifestyle interventions.
Second-Generation Clocks (PhenoAge, GrimAge)
These clocks were trained to predict mortality and disease outcomes rather than chronological age. GrimAge, developed by Ake Lu and Steve Horvath, incorporates DNA methylation surrogates for plasma proteins associated with mortality — including PAI-1, adrenomedullin, and smoking pack-years [3]. PhenoAge incorporates markers of immune function, liver function, and metabolic health.
Clinical utility: substantially better. GrimAge acceleration (biological age exceeding chronological age) predicts cardiovascular disease, cancer, and all-cause mortality independently of traditional risk factors.
Third-Generation Clocks (DunedinPACE)
DunedinPACE represents a fundamental shift — instead of estimating a static biological age, it measures the current pace of aging. Developed from the Dunedin longitudinal cohort study, it tracks the rate of decline across 19 biomarkers of organ function measured repeatedly over decades, then identifies the methylation signature associated with faster or slower decline [4].
A DunedinPACE score of 1.0 means you're aging at one year per calendar year (average). A score of 0.85 means you're aging 15% slower. A score of 1.2 means 20% faster.
Clinical utility: highest among epigenetic approaches. DunedinPACE responds to caloric restriction interventions, correlates with physical function measures, and predicts mortality within shorter follow-up windows than static clocks.
Limitations of Epigenetic Testing
Results take 6–12 months to shift meaningfully — not useful for short-term intervention tracking
Sample collection and processing variability can produce noise
Most consumer-facing tests use first-generation clocks that have limited clinical utility
Cost is significant for serial testing
Telomere Length Testing
Telomeres are the protective caps on chromosome ends that shorten with each cell division. Shorter telomeres are associated with cellular senescence, and average telomere length declines with age. The logic seems straightforward — shorter telomeres should indicate older biological age.
The reality is more complicated. Telomere length has high inter-individual variability, is influenced by genetics more than most aging markers, and has weak test-retest reliability in commercial assays. A single telomere length measurement tells you relatively little about your rate of aging or disease risk beyond what standard biomarkers already reveal [5].
When Telomere Testing Adds Value
Detecting extremely short telomeres (below the 10th percentile for age), which are associated with significantly elevated disease risk
Tracking trends over 2+ years with the same assay methodology
Research contexts with large sample sizes where individual measurement noise averages out
When It Doesn't
Single-point measurements for "how old am I really" — the uncertainty band is too wide
Short-term intervention tracking — telomere length doesn't meaningfully change in under 12 months
Comparing results between different testing services — methodological differences make cross-platform comparison unreliable
Blood Biomarker Panels — The Actionable Approach
Blood biomarker panels don't measure "aging" directly — they measure the functional outputs of aging: organ function decline, inflammatory burden, metabolic dysregulation, and hormonal shifts. Composite algorithms like PhenoAge (blood-based version), Levine's phenotypic age, and various commercial aging scores combine these markers into a single biological age estimate.
The advantage of this approach is actionability. Unlike methylation patterns or telomere length, blood biomarkers respond to interventions in weeks to months. You can measure your hsCRP, start an anti-inflammatory protocol, and see measurable improvement at your next blood draw 8–12 weeks later.
Key Longevity Biomarkers
Biomarker | What It Signals | Optimal Range (Longevity) | Responds To |
|---|---|---|---|
Systemic inflammation | < 0.5 mg/L | Diet, exercise, omega-3, sleep | |
Glycemic control | < 5.2% | Diet, exercise, sleep, stress | |
Atherogenic particle count | < 80 mg/dL | Diet, statins, exercise | |
Kidney filtration rate | Age-adjusted, lower is better | Hydration, BP control, metabolic health | |
Liver stress / oxidative burden | < 20 U/L | Alcohol reduction, weight loss | |
Liver synthetic function / nutritional status | 4.5–5.0 g/dL | Nutrition, protein intake | |
Immune aging | > 28% | Exercise, sleep, stress reduction | |
Adrenal reserve / hormonal aging | Upper half of age range | Sleep, stress management, exercise |
These markers collectively capture cardiovascular risk, metabolic health, immune aging, liver function, and hormonal status — the systems that drive most age-related disease and functional decline.
Limitations
No single blood panel captures all dimensions of aging (e.g., brain aging, musculoskeletal aging)
Acute illness, medication changes, or recent intense exercise can temporarily distort results
Composite scoring algorithms vary widely — different formulas applied to the same blood results can produce different "biological ages"
Glycan Analysis
GlycanAge measures the glycosylation patterns of immunoglobulin G (IgG) — the sugar structures attached to antibodies. These patterns shift predictably with age and inflammation status, and they respond to lifestyle interventions faster than epigenetic clocks [6].
The science is legitimate — IgG glycosylation correlates with inflammatory status, immune function, and age-related disease risk. The practical limitation is that glycan analysis captures primarily immune and inflammatory aging. It doesn't assess metabolic health, cardiovascular risk, or organ function independently.
Best use case: as a complement to blood biomarkers, particularly for people focused on inflammation reduction who want a biologically meaningful tracking metric.
Composite and Multi-Omic Approaches
The most comprehensive biological age assessments combine multiple data streams — blood biomarkers, epigenetic data, metabolomics, proteomics, and sometimes functional measures like grip strength, VO₂ max, or cognitive testing.
These approaches produce the richest aging profiles but come with trade-offs: higher cost, greater complexity in interpretation, and the challenge of determining which component is driving the overall score.
For most people optimizing their health, a well-designed blood biomarker panel provides 80% of the actionable signal at 20% of the cost of multi-omic approaches.
How to Choose Your Testing Strategy
Tier 1 — Start Here (Most People)
Comprehensive blood biomarker panel covering inflammation, metabolic health, cardiovascular risk, liver function, kidney function, and hormonal markers. This is the most cost-effective approach with the fastest feedback loop for intervention tracking.
Test every 3–6 months to establish trends and measure intervention response.
Tier 2 — Add Depth
Once blood biomarkers are optimized or you want a deeper aging signal, add an epigenetic clock test — preferably one offering DunedinPACE or GrimAge2. Test annually.
Tier 3 — Full Picture
Combine blood biomarkers (quarterly) with annual epigenetic testing and functional assessments (grip strength, VO₂ max testing, cognitive performance). This provides the broadest aging assessment available outside of research settings.
Track Your Biological Age With Precision
Mito Health tests over 70 biomarkers relevant to aging, including hsCRP, HbA1c, ApoB, cystatin C, DHEA-S, and hormonal panels — with physician-guided interpretation that connects the dots between individual markers and your overall aging trajectory. Individual testing starts at $349 and duo testing starts at $668.
Expected Timelines — When Results Change
Intervention | Blood Biomarkers | Epigenetic Clocks | Telomere Length |
|---|---|---|---|
Anti-inflammatory diet | 4–8 weeks | 6–12 months | 12+ months |
Regular exercise (150+ min/week) | 4–12 weeks | 6–12 months | 12–24 months |
Sleep optimization (7–9 hrs) | 2–6 weeks | 6–12 months | Unknown |
8–12 weeks | 6–12 months | 12+ months | |
Weight loss (5–10% body weight) | 4–12 weeks | 6–12 months | 12–24 months |
Stress reduction practices | 4–8 weeks | 6–12 months | Unknown |
Blood biomarkers provide the fastest feedback loop. This is why they're the foundation of any practical biological age tracking protocol — you can measure, intervene, and re-measure within a single quarter.
Common Mistakes
Taking a single biological age test result as definitive. All methods have uncertainty ranges. A biological age of 42 from one test doesn't mean you're biologically 42 — it means you're somewhere in a range around 42. Track trends, not single numbers.
Comparing results across different platforms. A GrimAge result and a blood biomarker composite score are measuring different things. They're not interchangeable.
Chasing the number instead of optimizing the inputs. Biological age is an output measure. Focus on improving the underlying drivers — inflammation, metabolic health, body composition, sleep, cardiovascular fitness — and the number follows.
Testing too frequently with epigenetic clocks. Methylation changes slowly. Testing more than once per year wastes money and produces noise that looks like signal.
Ignoring functional measures. Grip strength, VO₂ max, balance, and cognitive processing speed are powerful predictors of longevity that no blood test or DNA test captures [7].
Key Takeaways
Biological age tests measure different aspects of aging — no single test captures the full picture
Epigenetic clocks (especially DunedinPACE and GrimAge2) are the most scientifically validated single measure of aging rate
Blood biomarker panels offer the highest actionability — results shift in weeks to months, enabling rapid intervention tracking
Telomere length testing has limited clinical utility for individual health decisions due to high variability
The most practical strategy for most people: quarterly blood biomarker panels as the foundation, with optional annual epigenetic testing for deeper signal
Track trends over time rather than reacting to any single test result
Functional fitness measures (VO₂ max, grip strength) complement lab-based biological age testing and independently predict longevity
Know Your Biological Age
Mito Health tests 100+ biomarkers including epigenetic markers, telomere length proxies, inflammation, and metabolic health with physician-guided interpretation. Measure your true biological age and track your progress over time.
Medical Disclaimer
This guide is for educational purposes only and does not constitute medical advice. Biological age testing results should be interpreted in the context of your complete health history with guidance from a qualified healthcare provider. Do not make treatment decisions based solely on biological age test results. Individual variation in aging biomarkers is substantial — work with a physician who understands longevity medicine to design an appropriate testing and intervention strategy.
Track Your Progress
Monitor the biomarkers that drive biological age with regular testing:
Inflammation markers — hsCRP, IL-6, fibrinogen
Metabolic health — HbA1c, fasting glucose, insulin
Cardiovascular risk — ApoB, Lp(a), lipid panel
Hormonal aging — DHEA-S, testosterone, thyroid panel
Kidney function — cystatin C, eGFR
Related Content
How to Lower CRP and Chronic Inflammation: 8 Evidence-Based Methods
How to Raise Your Omega-3 Index Fast: 7 Evidence-Based Methods
References
Jylhävä J, Pedersen NL, Hägg S. Biological Age Predictors. EBioMedicine. 2017;21:29-36. doi:10.1016/j.ebiom.2017.03.046. PMID: [28396265](https://pubmed.ncbi.nlm.nih.gov/28396265/)
Horvath S. DNA methylation age of human tissues and cell types. Genome Biology. 2013;14(10):R115. doi:10.1186/gb-2013-14-10-r115. PMID: [24138928](https://pubmed.ncbi.nlm.nih.gov/24138928/)
Lu AT, Quach A, Wilson JG, et al. DNA methylation GrimAge strongly predicts lifespan and healthspan. Aging. 2019;11(2):303-327. doi:10.18632/aging.101684. PMID: [30669119](https://pubmed.ncbi.nlm.nih.gov/30669119/)
Belsky DW, Caspi A, Corcoran DL, et al. DunedinPACE, a DNA methylation biomarker of the pace of aging. eLife. 2022;11:e73420. doi:10.7554/eLife.73420. PMID: [35029144](https://pubmed.ncbi.nlm.nih.gov/35029144/)
Blackburn EH, Epel ES, Lin J. Human telomere biology: A contributory and interactive factor in aging, disease risks, and protection. Science. 2015;350(6265):1193-1198. doi:10.1126/science.aab3389. PMID: [26785477](https://pubmed.ncbi.nlm.nih.gov/26785477/)
Gudelj I, Lauc G, Pezer M. Immunoglobulin G glycosylation in aging and diseases. Cell Immunol. 2018;333:65-79. doi:10.1016/j.cellimm.2018.07.009. PMID: [30107893](https://pubmed.ncbi.nlm.nih.gov/30107893/)
Leong DP, Teo KK, Rangarajan S, et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet. 2015;386(9990):266-273. doi:10.1016/S0140-6736(14)62000-6. PMID: [25982160](https://pubmed.ncbi.nlm.nih.gov/25982160/)
Get a deeper look into your health.
Schedule online, results in a week
Clear guidance, follow-up care available
HSA/FSA Eligible
Get a deeper look into your health.
Schedule online, results in a week
Clear guidance, follow-up care available
HSA/FSA Eligible
Comments
Recently published
Recently published
What's included
1 Comprehensive lab test with over 100+ biomarkers
One appointment, test at 2,000+ labs nationwide
Insights calibrated to your biology
Recommendations informed by your ethnicity, lifestyle, and history. Not generic ranges.
1:1 Consultation
Meet with your dedicated care team to review your results and define next steps
Lifetime health record tracking
Upload past labs and monitor your progress over time
Biological age analysis
See how your body is aging and what’s driving it
Order add-on tests and scans anytime
Access to advanced diagnostics at discounted rates for members
Concierge-level care, made accessible.
Mito Health Membership
Codeveloped with experts at MIT & Stanford
Less than $1/ day
Billed annually - cancel anytime
Bundle options:
Individual
$399
$349
/year
or 4 interest-free payments of $87.25*
Duo Bundle
(For 2)
$798
$660
/year
or 4 interest-free payments of $167*
Pricing for members in NY, NJ & RI may vary.
Checkout with HSA/FSA
Secure, private platform
What's included
1 Comprehensive lab test with over 100+ biomarkers
One appointment, test at 2,000+ labs nationwide
Insights calibrated to your biology
Recommendations informed by your ethnicity, lifestyle, and history. Not generic ranges.
1:1 Consultation
Meet with your dedicated care team to review your results and define next steps
Lifetime health record tracking
Upload past labs and monitor your progress over time
Biological age analysis
See how your body is aging and what’s driving it
Order add-on tests and scans anytime
Access to advanced diagnostics at discounted rates for members
Concierge-level care, made accessible.
Mito Health Membership
Codeveloped with experts at MIT & Stanford
Less than $1/ day
Billed annually - cancel anytime
Bundle options:
Individual
$399
$349
/year
or 4 interest-free payments of $87.25*
Duo Bundle
(For 2)
$798
$660
/year
or 4 interest-free payments of $167*
Pricing for members in NY, NJ & RI may vary.
Checkout with HSA/FSA
Secure, private platform
What's included
1 Comprehensive lab test with over 100+ biomarkers
One appointment, test at 2,000+ labs nationwide
Insights calibrated to your biology
Recommendations informed by your ethnicity, lifestyle, and history. Not generic ranges.
1:1 Consultation
Meet with your dedicated care team to review your results and define next steps
Lifetime health record tracking
Upload past labs and monitor your progress over time
Biological age analysis
See how your body is aging and what’s driving it
Order add-on tests and scans anytime
Access to advanced diagnostics at discounted rates for members
Concierge-level care, made accessible.
Mito Health Membership
Codeveloped with experts at MIT & Stanford
Less than $1/ day
Billed annually - cancel anytime
Bundle options:
Individual
$399
$349
/year
or 4 interest-free payments of $87.25*
Duo Bundle (For 2)
$798
$660
/year
or 4 interest-free payments of $167*
Pricing for members in NY, NJ & RI may vary.
Checkout with HSA/FSA
Secure, private platform
What's included
1 Comprehensive lab test with over 100+ biomarkers
One appointment, test at 2,000+ labs nationwide
Insights calibrated to your biology
Recommendations informed by your ethnicity, lifestyle, and history. Not generic ranges.
1:1 Consultation
Meet with your dedicated care team to review your results and define next steps
Lifetime health record tracking
Upload past labs and monitor your progress over time
Biological age analysis
See how your body is aging and what’s driving it
Order add-on tests and scans anytime
Access to advanced diagnostics at discounted rates for members
Concierge-level care, made accessible.
Mito Health Membership
Codeveloped with experts at MIT & Stanford
Less than $1/ day
Billed annually - cancel anytime
Bundle options:
Individual
$399
$349
/year
or 4 payments of $87.25*
Duo Bundle
(For 2)
$798
$660
/year
or 4 payments of $167*
Pricing for members in NY, NJ & RI may vary.
Checkout with HSA/FSA
Secure, private platform